ReP USP - Resultado da busca

Artigo de periodico
Genetically determined variations of selenoprotein P are associated with antioxidant, muscular, and lipid biomarkers in response to Brazil nut consumption by patients using statins (2022)
Watanabe, Ligia Moriguchi ; Bueno, Ana Carolina; Lima, Livia F. de; Ferraz-Bannitz, Rafael; Dessordi, Renata; Guimarães, Mariana P.; Foss-Freitas, Maria Cristina; Barbosa Júnior, Fernando; Navarro, Anderson Marliere
Source: British Journal of Nutrition. Unidades: FMRP, FCFRP
Subjects: ANTIOXIDANTES, BIOMARCADORES, GLUTAMINA, PEROXIDASE, ESTATINAS, RNA MENSAGEIRO, SELÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WATANABE, Ligia Moriguchi et al. Genetically determined variations of selenoprotein P are associated with antioxidant, muscular, and lipid biomarkers in response to Brazil nut consumption by patients using statins. British Journal of Nutrition, v. 127, n. 5, p. 679-686, 2022Tradução . . Disponível em: https://doi.org/10.1017/S000711452100146X. Acesso em: 06 nov. 2024.
APA
Watanabe, L. M., Bueno, A. C., Lima, L. F. de, Ferraz-Bannitz, R., Dessordi, R., Guimarães, M. P., et al. (2022). Genetically determined variations of selenoprotein P are associated with antioxidant, muscular, and lipid biomarkers in response to Brazil nut consumption by patients using statins. British Journal of Nutrition, 127( 5), 679-686. doi:10.1017/S000711452100146X
NLM
Watanabe LM, Bueno AC, Lima LF de, Ferraz-Bannitz R, Dessordi R, Guimarães MP, Foss-Freitas MC, Barbosa Júnior F, Navarro AM. Genetically determined variations of selenoprotein P are associated with antioxidant, muscular, and lipid biomarkers in response to Brazil nut consumption by patients using statins [Internet]. British Journal of Nutrition. 2022 ; 127( 5): 679-686.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1017/S000711452100146X
Vancouver
Watanabe LM, Bueno AC, Lima LF de, Ferraz-Bannitz R, Dessordi R, Guimarães MP, Foss-Freitas MC, Barbosa Júnior F, Navarro AM. Genetically determined variations of selenoprotein P are associated with antioxidant, muscular, and lipid biomarkers in response to Brazil nut consumption by patients using statins [Internet]. British Journal of Nutrition. 2022 ; 127( 5): 679-686.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1017/S000711452100146X
Artigo de periodico
Dietary protein restriction improves metabolic dysfunction in patients with metabolic syndrome in a randomized, controlled trial (2022)
Ferraz-Bannitz, Rafael ; Beraldo, Rebeca Antunes ; Peluso, A. Augusto; Dall, Morten; Babaei, Parizad; Foglietti, Rayana Cardoso; Martins, Larissa Marfori; Gomes, Patricia Moreira; Marchini, Julio Sergio ; Suen, Vivian Marques Miguel; Freitas, Luiz Carlos Conti de ; Navegantes, Luiz Carlos Carvalho ; Pretti, Marco Antônio M.; Boroni, Mariana; Treebak, Jonas T.; Mori, Marcelo A; Foss, Milton Cesar ; Foss-Freitas, Maria Cristina
Source: Nutrients. Unidade: FMRP
Subjects: DIABETES MELLITUS INSULINO-DEPENDENTE, DOENÇAS CARDIOVASCULARES, DIETA COM RESTRIÇÃO DE PROTEÍNAS, OBESIDADE, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAZ-BANNITZ, Rafael et al. Dietary protein restriction improves metabolic dysfunction in patients with metabolic syndrome in a randomized, controlled trial. Nutrients, v. 14, n. 13, p. 1-18, 2022Tradução . . Disponível em: https://doi.org/10.3390/nu14132670. Acesso em: 06 nov. 2024.
APA
Ferraz-Bannitz, R., Beraldo, R. A., Peluso, A. A., Dall, M., Babaei, P., Foglietti, R. C., et al. (2022). Dietary protein restriction improves metabolic dysfunction in patients with metabolic syndrome in a randomized, controlled trial. Nutrients, 14( 13), 1-18. doi:10.3390/nu14132670
NLM
Ferraz-Bannitz R, Beraldo RA, Peluso AA, Dall M, Babaei P, Foglietti RC, Martins LM, Gomes PM, Marchini JS, Suen VMM, Freitas LCC de, Navegantes LCC, Pretti MAM, Boroni M, Treebak JT, Mori MA, Foss MC, Foss-Freitas MC. Dietary protein restriction improves metabolic dysfunction in patients with metabolic syndrome in a randomized, controlled trial [Internet]. Nutrients. 2022 ; 14( 13): 1-18.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/nu14132670
Vancouver
Ferraz-Bannitz R, Beraldo RA, Peluso AA, Dall M, Babaei P, Foglietti RC, Martins LM, Gomes PM, Marchini JS, Suen VMM, Freitas LCC de, Navegantes LCC, Pretti MAM, Boroni M, Treebak JT, Mori MA, Foss MC, Foss-Freitas MC. Dietary protein restriction improves metabolic dysfunction in patients with metabolic syndrome in a randomized, controlled trial [Internet]. Nutrients. 2022 ; 14( 13): 1-18.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3390/nu14132670
Artigo de periodico
Bariatric surgery can acutely modulate ER-stress and inflammation on subcutaneous adipose tissue in non-diabetic patients with obesity (2021)
Ferraz-Bannitz, Rafael; Welendorf, Caroline Rossi; Coelho, Priscila Oliveira; Salgado Júnior, Wilson; Nonino, Carla Barbosa ; Beraldo, Rebeca Antunes; Foss-Freitas, Maria Cristina
Source: Diabetology & Metabolic Syndrome. Unidade: FMRP
Subjects: CIRURGIA BARIÁTRICA, TECIDO ADIPOSO, ESTRESSE OXIDATIVO, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAZ-BANNITZ, Rafael et al. Bariatric surgery can acutely modulate ER-stress and inflammation on subcutaneous adipose tissue in non-diabetic patients with obesity. Diabetology & Metabolic Syndrome, v. 13, n. 1, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1186/s13098-021-00623-w. Acesso em: 06 nov. 2024.
APA
Ferraz-Bannitz, R., Welendorf, C. R., Coelho, P. O., Salgado Júnior, W., Nonino, C. B., Beraldo, R. A., & Foss-Freitas, M. C. (2021). Bariatric surgery can acutely modulate ER-stress and inflammation on subcutaneous adipose tissue in non-diabetic patients with obesity. Diabetology & Metabolic Syndrome, 13( 1), 1-11. doi:10.1186/s13098-021-00623-w
NLM
Ferraz-Bannitz R, Welendorf CR, Coelho PO, Salgado Júnior W, Nonino CB, Beraldo RA, Foss-Freitas MC. Bariatric surgery can acutely modulate ER-stress and inflammation on subcutaneous adipose tissue in non-diabetic patients with obesity [Internet]. Diabetology & Metabolic Syndrome. 2021 ; 13( 1): 1-11.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/s13098-021-00623-w
Vancouver
Ferraz-Bannitz R, Welendorf CR, Coelho PO, Salgado Júnior W, Nonino CB, Beraldo RA, Foss-Freitas MC. Bariatric surgery can acutely modulate ER-stress and inflammation on subcutaneous adipose tissue in non-diabetic patients with obesity [Internet]. Diabetology & Metabolic Syndrome. 2021 ; 13( 1): 1-11.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/s13098-021-00623-w

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation